- Home
- CGBD vs LENZ Comparison
CGBD vs LENZ Comparison
Compare CGBD & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGBD
- LENZ
- Stock Information
- Founded
- CGBD 2012
- LENZ 2019
- Country
- CGBD United States
- LENZ United States
- Employees
- CGBD N/A
- LENZ N/A
- Industry
- CGBD Finance: Consumer Services
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- CGBD Finance
- LENZ Health Care
- Exchange
- CGBD Nasdaq
- LENZ Nasdaq
- Market Cap
- CGBD 1.0B
- LENZ 1.1B
- IPO Year
- CGBD 2017
- LENZ 2021
- Fundamental
- Price
- CGBD $13.79
- LENZ $41.98
- Analyst Decision
- CGBD Hold
- LENZ Strong Buy
- Analyst Count
- CGBD 5
- LENZ 4
- Target Price
- CGBD $14.63
- LENZ $49.75
- AVG Volume (30 Days)
- CGBD 412.0K
- LENZ 706.3K
- Earning Date
- CGBD 11-04-2025
- LENZ 11-05-2025
- Dividend Yield
- CGBD 12.33%
- LENZ N/A
- EPS Growth
- CGBD N/A
- LENZ N/A
- EPS
- CGBD 1.14
- LENZ N/A
- Revenue
- CGBD $234,464,000.00
- LENZ $5,000,000.00
- Revenue This Year
- CGBD $14.68
- LENZ N/A
- Revenue Next Year
- CGBD $5.53
- LENZ $258.37
- P/E Ratio
- CGBD $12.05
- LENZ N/A
- Revenue Growth
- CGBD N/A
- LENZ N/A
- 52 Week Low
- CGBD $13.12
- LENZ $16.54
- 52 Week High
- CGBD $18.64
- LENZ $42.08
- Technical
- Relative Strength Index (RSI)
- CGBD 48.78
- LENZ 66.44
- Support Level
- CGBD $13.73
- LENZ $36.81
- Resistance Level
- CGBD $14.00
- LENZ $40.35
- Average True Range (ATR)
- CGBD 0.19
- LENZ 1.84
- MACD
- CGBD 0.01
- LENZ 0.04
- Stochastic Oscillator
- CGBD 58.12
- LENZ 98.27
About CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.